TIA
Traphagen Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-98,840
| Closed | -$8.22M | – | 170 |
|
|
2023
Q2 | $8.22M | Buy |
98,840
+1,684
| +2% | +$140K | 1.07% | 18 |
|
|
2023
Q1 | $7.41M | Buy |
97,156
+1,012
| +1% | +$77.2K | 1.09% | 16 |
|
|
2022
Q4 | $7.98M | Buy |
96,144
+784
| +0.8% | +$65.1K | 1.25% | 16 |
|
|
2022
Q3 | $7.56M | Sell |
95,360
-67
| -0.1% | -$5.31K | 1.39% | 17 |
|
|
2022
Q2 | $7.09M | Buy |
95,427
+7,444
| +8% | +$553K | 1.29% | 18 |
|
|
2022
Q1 | $7.91M | Sell |
87,983
-19,253
| -18% | -$1.73M | 1.28% | 17 |
|
|
2021
Q4 | $6.32M | Sell |
107,236
-28,975
| -21% | -$1.71M | 1.04% | 16 |
|
|
2021
Q3 | $8.3M | Buy |
136,211
+115,739
| +565% | +$7.05M | 1.49% | 14 |
|
|
2021
Q2 | $1.37M | Buy |
20,472
+8,179
| +67% | +$547K | 0.23% | 36 |
|
|
2021
Q1 | $832K | Buy |
+12,293
| New | +$832K | 0.15% | 57 |
|